Commentary: Moving the dial on DOAC use early after cardiac surgery

Atrial fibrillation remains an unsolved complication after cardiac surgery with published rates in the 20-50%1,2. As outlined in a recent STS database analysis3, over 60% of US surgeons still use warfarin rather than switching to direct oral anticoagulants (DOACs) for stroke prophylaxis in this clinical scenario. This trend persists despite the limitations associated with warfarin use, including prolonged and often turbulent early titration in new patients, dietary restrictions, strict monitoring requirements and extensive medication interactions.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ADULT – Commentary Source Type: research